Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cullinan

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulatorR F Kauffman, W R Bensch, R E Roudebush, et al.
Cancer Research|September 1, 1978
Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in cultureM J Sweeney, G B Boder, G J Cullinan, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulationC C Felder, K E Joyce, E M Briley, et al.
Journal of Medicinal Chemistry|May 9, 1997
Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulatorA D Palkowitz, A L Glasebrook, K J Thrasher, et al.
Journal of Medicinal Chemistry|January 1, 1978
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfateC J Barnett, G J Cullinan, K Gerzon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Molecular determinants of tissue selectivity in estrogen receptor modulatorsT A Grese, J P Sluka, H U Bryant, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Hypocholesterolemic activity of raloxifene (LY139481): pharmacological characterization as a selective estrogen receptor modulatorR F Kauffman, W R Bensch, R E Roudebush, et al.
Cancer Research|September 1, 1978
Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in cultureM J Sweeney, G B Boder, G J Cullinan, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulationC C Felder, K E Joyce, E M Briley, et al.
Journal of Medicinal Chemistry|May 9, 1997
Discovery and synthesis of [6-hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-2-(4-hydroxyphenyl)]b enzo[b]thiophene: a novel, highly potent, selective estrogen receptor modulatorA D Palkowitz, A L Glasebrook, K J Thrasher, et al.
Journal of Medicinal Chemistry|January 1, 1978
Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfateC J Barnett, G J Cullinan, K Gerzon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Molecular determinants of tissue selectivity in estrogen receptor modulatorsT A Grese, J P Sluka, H U Bryant, et al.
Pageof 8